IMAB – I-Mab ADR
I-MABIMAB
$0.9199Name : I-MAB
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $74,972,864.00
EPSttm : -0.62
I-MAB
$0.9199
2.66%$0.0251Float Short %
0.34
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
-0.01
Price
0.92
Target Price
5.5
Analyst Recom
1
Performance Q
-5.16
Relative Volume
0.22
Beta
1.03
Ticker: IMAB
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-04-14 | IMAB | 0.9563 | 0.15 | 0.00 | 1040 |
| 2025-04-15 | IMAB | 0.9198 | 0.15 | 0.00 | 1040 |
| 2025-04-16 | IMAB | 0.8404 | 0.15 | 0.00 | 1040 |
| 2025-04-17 | IMAB | 0.85 | 0.15 | 0.00 | 1040 |
| 2025-04-18 | IMAB | 0.8452 | 0.15 | 0.00 | 1040 |
| 2025-04-21 | IMAB | 0.8565 | 0.00 | 0.00 | 512 |
| 2025-04-22 | IMAB | 0.8304 | 0.00 | 0.00 | 519 |
| 2025-04-23 | IMAB | 0.8401 | 0.00 | 0.00 | 523 |
| 2025-04-24 | IMAB | 0.8178 | 0.00 | 0.00 | 523 |
| 2025-04-25 | IMAB | 0.8394 | 0.0019157088122605 | 0 | 523 |
| 2025-04-28 | IMAB | 0.8105 | 0.0019157088122605 | 0 | 523 |
| 2025-04-29 | IMAB | 0.8106 | 0.00 | 0.00 | 523 |
| 2025-04-30 | IMAB | 0.94 | 0.00 | 0.00 | 523 |
| 2025-05-01 | IMAB | 0.91 | 0.00 | 0.00 | 533 |
| 2025-05-02 | IMAB | 0.9285 | 0.00 | 0.00 | 533 |
| 2025-05-05 | IMAB | 0.8506 | 0.00 | 0.00 | 533 |
| 2025-05-06 | IMAB | 0.8924 | 0.00 | 0.00 | 533 |
| 2025-05-07 | IMAB | 0.8916 | 0.00 | 0.00 | 533 |
| 2025-05-08 | IMAB | 0.8763 | 0.00 | 0.00 | 533 |
| 2025-05-09 | IMAB | 0.8527 | N/A | N/A | 0 |
| 2025-05-12 | IMAB | 0.9449 | N/A | N/A | 0 |
| 2025-05-13 | IMAB | 0.912 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-04-14 | IMAB | 0.96 | - | - | -0.28 |
| 2025-04-15 | IMAB | 0.91 | - | - | -0.28 |
| 2025-04-16 | IMAB | 0.85 | - | - | -0.28 |
| 2025-04-17 | IMAB | 0.85 | - | - | -0.28 |
| 2025-04-18 | IMAB | 0.85 | - | - | -0.28 |
| 2025-04-21 | IMAB | 0.83 | - | - | -0.28 |
| 2025-04-22 | IMAB | 0.83 | - | - | -0.28 |
| 2025-04-23 | IMAB | 0.85 | - | - | -0.28 |
| 2025-04-24 | IMAB | 0.84 | - | - | -0.28 |
| 2025-04-25 | IMAB | 0.84 | - | - | -0.28 |
| 2025-04-28 | IMAB | 0.81 | - | - | -0.28 |
| 2025-04-29 | IMAB | 0.81 | - | - | -0.28 |
| 2025-04-30 | IMAB | 0.94 | - | - | -0.28 |
| 2025-05-01 | IMAB | 0.87 | - | - | -0.28 |
| 2025-05-02 | IMAB | 0.95 | - | - | -0.28 |
| 2025-05-05 | IMAB | 0.86 | - | - | -0.28 |
| 2025-05-06 | IMAB | 0.87 | - | - | -0.28 |
| 2025-05-07 | IMAB | 0.89 | - | - | -0.28 |
| 2025-05-08 | IMAB | 0.84 | - | - | -0.28 |
| 2025-05-09 | IMAB | 0.88 | - | - | -0.28 |
| 2025-05-12 | IMAB | 0.94 | - | - | -0.28 |
| 2025-05-13 | IMAB | 0.92 | - | - | -0.28 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-04-14 | IMAB | 0.00 | -27.21 | 0.42 |
| 2025-04-15 | IMAB | 0.00 | -27.21 | 0.42 |
| 2025-04-16 | IMAB | 0.00 | -27.21 | 0.42 |
| 2025-04-17 | IMAB | 0.00 | -27.21 | 0.42 |
| 2025-04-18 | IMAB | 0.00 | -27.21 | 0.42 |
| 2025-04-21 | IMAB | 0.00 | -27.29 | 0.42 |
| 2025-04-22 | IMAB | 0.00 | -27.29 | 0.42 |
| 2025-04-23 | IMAB | 0.00 | -27.29 | 0.42 |
| 2025-04-24 | IMAB | 0.00 | -27.29 | 0.42 |
| 2025-04-25 | IMAB | 0.00 | -27.29 | 0.42 |
| 2025-04-28 | IMAB | 0.00 | -20.76 | 0.54 |
| 2025-04-29 | IMAB | 0.00 | -20.76 | 0.54 |
| 2025-04-30 | IMAB | 0.00 | -20.76 | 0.54 |
| 2025-05-01 | IMAB | 0.00 | -20.76 | 0.54 |
| 2025-05-02 | IMAB | 0.00 | -20.76 | 0.54 |
| 2025-05-05 | IMAB | 0.00 | -20.14 | 0.54 |
| 2025-05-06 | IMAB | 0.00 | -20.14 | 0.54 |
| 2025-05-07 | IMAB | 0.00 | -20.14 | 0.54 |
| 2025-05-08 | IMAB | 0.00 | -20.14 | 0.54 |
| 2025-05-09 | IMAB | 0.00 | -20.14 | 0.54 |
| 2025-05-12 | IMAB | 0.00 | -20.15 | 0.34 |
| 2025-05-13 | IMAB | 0.00 | -20.15 | 0.34 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.05
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
Institutional Transactions
-20.15
Beta
1.03
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
13
Growth Score
20
Sentiment Score
67
Actual DrawDown %
98.9
Max Drawdown 5-Year %
-99.3
Target Price
5.5
P/E
Forward P/E
PEG
P/S
P/B
0.36
P/Free Cash Flow
EPS
-0.71
Average EPS Est. Cur. Y
-0.28
EPS Next Y. (Est.)
-0.29
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.22
Return on Equity vs Sector %
-34.7
Return on Equity vs Industry %
-17.8
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.18
EBIT Estimation
I-MABSector: Healthcare
Industry: Biotechnology
Employees: 32
I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
stock quote shares IMAB – I-Mab ADR Stock Price stock today
news today IMAB – I-Mab ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch IMAB – I-Mab ADR yahoo finance google finance
stock history IMAB – I-Mab ADR invest stock market
stock prices IMAB premarket after hours
ticker IMAB fair value insiders trading